CVD is the Worlds Leading Killer…By Far
Cardiovascular disease is our number one public health challenge and more people die annually from CVDs than from any other cause. The World Health Organization estimates that 17.7 million people died from CVDs in 2015. This is nearly third of all global deaths. This includes an estimated 7.4 million deaths from coronary heart disease and 6.7 million from stroke.
Innovation Is the engine for Change and Investors and Entrepreneur provide the Fuel and Spark
Advanced Bifurcation Systems has developed a novel, potentially revolutionary mother-daughter coronary stenting platform that has the potential to reduce the duration of stenting procedures, improve the reliability of bifurcation disease stenting and simplify the procedure for practitioners. So I am presenting at noon this Thursday, August 23rd in at the 2018 Southern California Investor Conference. The conference will be at the Balboa Bay Resort in Newport Beach. I am expecting up to 300 investors will come and hear about the opportunity.
Analysts report that the coronary stent market is expected to reach $10B in 2025. Bifurcation disease could be about 25% of this market. ABS represents a great opportunity for family office investors who seek to make a real impact on the future of healthcare. So as Family Office Networks Founder Andrew Schneider recently put it, “We believe ABS is poised to capture a significant part of this $2.5B market as the only true and complete bifurcating stent delivery platform in the market.”
I hope you will join us